HAE

Clinical trials for HAE explained in plain language.

Never miss a new study

Get alerted when new HAE trials appear

Sign up with your email to follow new studies for HAE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

Patients get extended access to promising HAE drug in 10-Year safety study

Disease control ENROLLING_BY_INVITATION

This study provides continued access to the oral medication berotralstat for people with hereditary angioedema (HAE) who were in previous trials. It aims to monitor the long-term safety and tolerability of the drug for up to 10 years in adults and adolescents, and up to 5 years i…

Matched conditions: HAE

Phase: PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control

Last updated Mar 25, 2026 14:07 UTC

HAE

Get alerted when new HAE trials appear

Patients get extended access to promising HAE drug in 10-Year safety study